Literature DB >> 24183462

Choosing the net survival method for cancer survival estimation.

Karri Seppä1, Timo Hakulinen2, Arun Pokhrel3.   

Abstract

BACKGROUND: A new net survival method has been introduced by Pohar Perme et al. (2012 [4]) and recommended to substitute the relative survival methods in current use for evaluating population-based cancer survival.
METHODS: The new method is based on the use of continuous follow-up time, and is unbiased only under non-informative censoring of the observed survival. However, the population-based cancer survival is often evaluated based on annually or monthly tabulated follow-up intervals. An empirical investigation based on data from the Finnish Cancer Registry was made into the practical importance of the censoring and the level of data tabulation. A systematic comparison was made against the earlier recommended Ederer II method of relative survival using the two currently available computer programs (Pohar Perme (2013) [10] and Dickman et al. (2013) [11]).
RESULTS: With exact or monthly tabulated data, the Pohar-Perme and the Ederer II methods give, on average, results that are at five years of follow-up less than 0.5% units and at 10 and 14 years 1-2% units apart from each other. The Pohar-Perme net survival estimator is prone to random variation and may result in biased estimates when exact follow-up times are not available or follow-up is incomplete. With annually tabulated follow-up times, estimates can deviate substantially from those based on more accurate observations, if the actuarial approach is not used.
CONCLUSION: At 5 years, both the methods perform well. In longer follow-up, the Pohar-Perme estimates should be interpreted with caution using error margins. The actuarial approach should be preferred, if data are annually tabulated.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epidemiologic methods; Models; Neoplasms; Net survival; Prognosis; Relative survival

Mesh:

Year:  2013        PMID: 24183462     DOI: 10.1016/j.ejca.2013.09.019

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  6 in total

1.  Five-Year Cancer Survival Rates in Oklahoma from 1997 to 2008.

Authors:  Janis Campbell; Krupa Gandhi; Anne Pate; Amanda Janitz; Amber Anderson; Robin Kinnard; Kai Ding
Journal:  J Okla State Med Assoc       Date:  2016 Jul-Aug

2.  Comparison of different approaches to estimating age standardized net survival.

Authors:  Paul C Lambert; Paul W Dickman; Mark J Rutherford
Journal:  BMC Med Res Methodol       Date:  2015-08-15       Impact factor: 4.615

Review 3.  Critical Points for Interpreting Patients' Survival Rate Using Cancer Registries: A Literature Review.

Authors:  Ayako Okuyama; Akiko Shibata; Hiroshi Nishimoto
Journal:  J Epidemiol       Date:  2017-10-28       Impact factor: 3.211

4.  Net Survival in Survival Analyses for Patients with Cancer: A Scoping Review.

Authors:  Camila Macedo Lima Nagamine; Bárbara Niegia Garcia de Goulart; Patrícia Klarmann Ziegelmann
Journal:  Cancers (Basel)       Date:  2022-07-06       Impact factor: 6.575

5.  Under-treatment of elderly patients with ovarian cancer: a population based study.

Authors:  Elisabeth Fourcadier; Brigitte Trétarre; Claudine Gras-Aygon; Fiona Ecarnot; Jean-Pierre Daurès; Faïza Bessaoud
Journal:  BMC Cancer       Date:  2015-11-26       Impact factor: 4.430

6.  Analysing population-based cancer survival - settling the controversies.

Authors:  Maja Pohar Perme; Jacques Estève; Bernard Rachet
Journal:  BMC Cancer       Date:  2016-12-03       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.